Search research articles
Contact Us
Filters
Showing results (101-110 of 154) with videos related to
Page
of 16
Sort By:
Brain : a Journal of Neurology
|
May 10, 2018
JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis
Leandro Ladislau, Xavier Suárez-Calvet, Ségolène Toquet, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 27, 2021
Monoclonal antibody-mediated neutralization of SARS-CoV-2 in an IRF9-deficient child
Romain Lévy, Peng Zhang, Paul Bastard, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 19, 2013
Longitudinal and integrative biomodeling of effector and memory immune compartments after inactivated influenza vaccination
Olivia Bonduelle, Nora Yahia, Sophie Siberil, et al.
The Journal of Experimental Medicine
|
August 2, 2012
Heterozygous TBK1 mutations impair TLR3 immunity and underlie herpes simplex encephalitis of childhood
Melina Herman, Michael Ciancanelli, Yi-Hung Ou, et al.
Journal of Gynecology Obstetrics and Human Reproduction
|
March 16, 2024
Maternal and neonatal outcomes of French prospective multicenter cohort study COVIPREG during the first two COVID-19 waves
Alexandre J Vivanti, Camille Couffignal, Jeanne Sibiude, et al.
Immunity
|
September 14, 2010
Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis
Rebeca Pérez de Diego, Vanessa Sancho-Shimizu, Lazaro Lorenzo, et al.
Journal of Crohn'S & Colitis
|
September 10, 2015
Immunogenicity and Safety of Influenza Vaccine in Inflammatory Bowel Disease Patients Treated or not with Immunomodulators and/or Biologics: A Two-year Prospective Study
Odile Launay, Vered Abitbol, Anne Krivine, et al.
Neurology
|
October 24, 2014
TLR3 deficiency in herpes simplex encephalitis: high allelic heterogeneity and recurrence risk
Hye Kyung Lim, Mikko Seppänen, Timo Hautala, et al.
Cytokine
|
May 4, 2021
Differential levels of IFNα subtypes in autoimmunity and viral infection
Vincent Bondet, Mathieu P Rodero, Céline Posseme, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
August 4, 2022
Pre-exposure prophylaxis with tixagevimab and cilgavimab (Evusheld) for COVID-19 among 1112 severely immunocompromised patients
Yann Nguyen, Adrien Flahault, Nathalie Chavarot, et al.
Page
of 16
Search research articles
Search
Showing results (101-110 of 154) with videos related to
Sort By:
Page
of 16
Brain : a Journal of Neurology
|
May 10, 2018
JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis
Leandro Ladislau, Xavier Suárez-Calvet, Ségolène Toquet, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 27, 2021
Monoclonal antibody-mediated neutralization of SARS-CoV-2 in an IRF9-deficient child
Romain Lévy, Peng Zhang, Paul Bastard, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 19, 2013
Longitudinal and integrative biomodeling of effector and memory immune compartments after inactivated influenza vaccination
Olivia Bonduelle, Nora Yahia, Sophie Siberil, et al.
The Journal of Experimental Medicine
|
August 2, 2012
Heterozygous TBK1 mutations impair TLR3 immunity and underlie herpes simplex encephalitis of childhood
Melina Herman, Michael Ciancanelli, Yi-Hung Ou, et al.
Journal of Gynecology Obstetrics and Human Reproduction
|
March 16, 2024
Maternal and neonatal outcomes of French prospective multicenter cohort study COVIPREG during the first two COVID-19 waves
Alexandre J Vivanti, Camille Couffignal, Jeanne Sibiude, et al.
Immunity
|
September 14, 2010
Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis
Rebeca Pérez de Diego, Vanessa Sancho-Shimizu, Lazaro Lorenzo, et al.
Journal of Crohn'S & Colitis
|
September 10, 2015
Immunogenicity and Safety of Influenza Vaccine in Inflammatory Bowel Disease Patients Treated or not with Immunomodulators and/or Biologics: A Two-year Prospective Study
Odile Launay, Vered Abitbol, Anne Krivine, et al.
Neurology
|
October 24, 2014
TLR3 deficiency in herpes simplex encephalitis: high allelic heterogeneity and recurrence risk
Hye Kyung Lim, Mikko Seppänen, Timo Hautala, et al.
Cytokine
|
May 4, 2021
Differential levels of IFNα subtypes in autoimmunity and viral infection
Vincent Bondet, Mathieu P Rodero, Céline Posseme, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
August 4, 2022
Pre-exposure prophylaxis with tixagevimab and cilgavimab (Evusheld) for COVID-19 among 1112 severely immunocompromised patients
Yann Nguyen, Adrien Flahault, Nathalie Chavarot, et al.
Page
of 16